Activated protein C resistance shows an association with pregnancy-induced hypertension

Human Reproduction

Volumn 14, Issue 12, 1999, Pages 3112-3115

  Horstkamp, B S ^a   Kiess, H ^a   Kramer J ^a   Riess, H ^a   Henrich, W ^a   Dudenhausen, J W ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

APC resistance; Factor V Leiden mutation; Placental infarction; Pre eclampsia; Pregnancy induced hypertension

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; INFARCTION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MICROEMBOLISM; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREVALENCE;

EID: 0032742007     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.12.3112     Document Type: Article

References (20)

1. Bertina, R.M., Koelemann, R.P.C., Koster, T. et al. (1994) Mutation in blood coagulation factor V associated with resistance to APC. Nature, 369, 64-67.
2. 506 to Gln mutation in factor V as pathogenic risk factor for venous thrombosis. Throm. Haemost., 74, 139-148.
3. Dekker, G.A., de Vries, J.I.P., Doelitzsch, P.M. et al. (1995) Underlying disorders associated with severe early-onset pre-eclampsia. Am. J. Obstet. Gynecol., 175, 1042-1048.
4. Dekker, G.A. (1994) Etiology and pathophysiology of pre-eclampsia. Zentralb. Gynäkol., 116, 57-60.
5. Dizon-Tawnson, D.S., Nelson, L.M., Eason, K. et al. (1996) The factor V Leiden mutation may predispose women to severe pre-eclampsia. Am. J. Obstet. Gynecol., 175, 902-905.
6. Dizon-Townson, D.S., Nelson, L.M., Jang, H. et al. (1997) The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am. J. Obstet. Gynecol., 176, 883-886.
7. Hellgren, M., Svensson, P.J. and Dahlbäck, B. (1995) Resistance to APC as a basis for venous thrombo-embolism associated with pregnancy and oral contraceptives. Am. J. Obstet. Gynecol., 173, 210-213.
8. Hintz, G., Riess, H. and Huhn, D. (1995) Akzelerin-Inaktivierung bestimmt Resistenz gegenüber aktiviertem Protein C. Klin. Lab., 41, 113-117.
9. Horstkamp, B.S., Lübke, M., Kentenich, H. et al. (1996a) Internal jugular vein thrombosis caused by resistance to APC as a complication of ovarian hyperstimulation after in-vitro fertilization (case report). Hum. Reprod., 11. 280-282.
10. Horstkamp, B.S., Siemann, A., Kentenich, H. et al. (1996b) Resistance to APC is a thrombolic risk factor in an IVF programme. Hum. Reprod., 11, 145.
11. Khong, T.Y. and Mott, C. (1993) Immunohistologic demonstration of endothelial disruption in acute atherosis in pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 51, 193-197.
12. Koster, T., Rosendaal, F.R., de Ronde, H. et al. (1993) Venous thrombosis due to poor anticoagulant response to APC: Leiden Thrombophilia Study. Lancet, 342, 1503-1506.
13. Kupfermine, M.J., Eldor, A., Steinman, N. et al. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med., 340, 9-13.
14. Lindoff, C., Ingemarsson, I., Martinsson, G. et al. (1997) Preeclampsia is associated with a reduced response to APC. Am. J. Obstet. Gynecol., 176, 457-460.
15. øian, P. (1997) Preeclampsia - pathophysiology and hemodynamics. In Läkemedelsverket (Sweden) and Statens Legemiddelkontroll (Norway) (eds), Workshop Treatment of Hypertension in Pregnancy. Guiden Tryck, Bromma, pp. 29-39.
16. Rees, D.C., Cox, M. and Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133-1134.
17. Roberts, J.M. (1989) Pregnancy related hypertension. In Creasy, R.K. and Resnik, R. (eds), Maternal Fetal Medicine: Principles and Practice. Saunders, Philadelphia.
18. Roberts, J.M., Taylor, R.N., Musci, T.J. et al. (1989) Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol., 161, 1200-1204.
19. Svensson, P.J. and Dahlbäck, B. (1994) Resistance to APC as a basis for venous thrombosis. N. Engl. J. Med., 330, 517-522.
20. Vandenbroucke, J.P., Koster, T., Briët, E. et al. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 344, 1453-1457.